The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular profiling as a predictor of treatment response and survival in unresectable pancreatic ductal adenocarcinoma.
 
Rodrigo Paredes
No Relationships to Disclose
 
Marcela Banegas
No Relationships to Disclose
 
Santiago Sucre
No Relationships to Disclose
 
Cristina Ponce
No Relationships to Disclose
 
Ahmed Anwer Ali Rattani
Stock and Other Ownership Interests - 2seventy bio; Actinium Pharmaceuticals; Agenus; Bluebird Bio; Compass Therapeutics; ImmunityBio; Macrogenics; Magenta Therapeutics; Mirati Therapeutics; Xencor
 
Mary Linton Bounetheau Peters
Stock and Other Ownership Interests - Abbott Laboratories (I); Abbott Laboratories (I); Agios; Amgen (I); Johnson & Johnson (I); Lilly; Lilly (I); Medtronic; Medtronic (I); Merck; Merck (I); Pfizer (I); Procter & Gamble
Consulting or Advisory Role - Agios
Research Funding - AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Berg Pharma (Inst); Exelixis (Inst); Helsinn Therapeutics (Inst); Lilly (Inst); Merck (Inst); Nucana (Inst); Taiho Pharmaceutical (Inst)